Torthaí cuardaigh - Geetha, Duvuru

Beachtaigh na torthaí
  1. 1
    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis

    Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis de réir Shah, Shivani, Geetha, Duvuru

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis

    Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis de réir Kant, Sam, Geetha, Duvuru

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature

    Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literatur... de réir Lee, Scott M, Geetha, Duvuru

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Keeping Up with the Times: Prognostic Tools in ANCA-Associated Glomerulonephritis

    Keeping Up with the Times: Prognostic Tools in ANCA-Associated Glomerulonephritis de réir Brix, Silke R., Geetha, Duvuru

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis

    Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis de réir Kant, Sam, Azar, Antoine, Geetha, Duvuru

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study

    Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study de réir Manno, Rebecca L., Seo, Philip, Geetha, Duvuru

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model?

    Additional Refinement of CKD Prognostication Using Lymphatic Vessel Density: IgA Nephropathy as the Role Model? de réir Kronbichler, Andreas, Shin, Jae Il, Geetha, Duvuru

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Immune checkpoint inhibitors as potential triggers for ANCA vasculitis

    Immune checkpoint inhibitors as potential triggers for ANCA vasculitis de réir Aqeel, Faten, Monroy-Trujillo, Jose, Geetha, Duvuru

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis

    Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis de réir Shah, Shivani, Jaggi, Khushleen, Greenberg, Keiko, Geetha, Duvuru

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis

    Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis de réir Jin, Qiuyu, Kant, Sam, Alhariri, Jihad, Geetha, Duvuru

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Outcomes of hydralazine induced renal vasculitis

    Outcomes of hydralazine induced renal vasculitis de réir Timlin, Homa, Liebowitz, Jason E., Jaggi, Khusleen, Geetha, Duvuru

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic

    Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic de réir Gapud, Eric J., Kronbichler, Andreas, Gauckler, Philipp, Geetha, Duvuru

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis

    Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis de réir Ghosh, Jyotsna, Kant, Sam, Kastner, Isabel Villegas, Geetha, Duvuru

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis

    Hematuria duration does not predict kidney function at 1 year in ANCA-associated glomerulonephritis de réir Chen, Teresa K., Murakami, Christine, Manno, Rebecca L., Geetha, Duvuru

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis

    Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis de réir Dein, Eric J, Crespo-Bosque, Monica, Timlin, Homa, Geetha, Duvuru

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists

    Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists de réir Kant, Sam, Kronbichler, Andreas, Salas, Antonio, Bruchfeld, Annette, Geetha, Duvuru

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy

    Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy de réir Gapud, Eric J, Manno, Rebecca, Seo, Philip, Hanouneh, Mohamad, Geetha, Duvuru

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors

    Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors de réir Isaacs, Bradley, Gapud, Eric J., Antiochos, Brendan, Seo, Philip, Geetha, Duvuru

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage

    Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage de réir Dein, Eric, Manno, Rebecca, Syed, Abrahim, Douglas, Homeyra, Geetha, Duvuru, Timlin, Homa

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis de réir Kant, Sam, Raman, Gaurav, Damera, Pranav, Antiochos, Brendan, Seo, Philip, Geetha, Duvuru

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán
    Téacs
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: